Table 1 Demographic and Clinical Characteristics of 559 Participants with MDR-TB Treated at Hinduja Hospital, by Prior MDR-TB Treatment
From: Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
Prior MDR-TB Treatment, N = 267 | No Prior MDR-TB Treatment, N = 289 | All Participants, N = 559 | Χ2 Test | |
|---|---|---|---|---|
#/# with Complete Dataa (%) | #/# with Complete Dataa (%) | #/# with Complete Dataa (%) | p-value | |
Female | 163 / 267 (61.0) | 184 / 289 (63.7) | 349 / 559 (62.4) | 0.583 |
Diagnosed in Private Sector | 227 / 254 (89.4) | 215 / 269 (79.9) | 444 / 525 (84.6) | 0.004 |
Current Student | 66 / 267 (24.7) | 67 / 289 (23.2) | 133 / 559 (23.8) | 0.746 |
Health Care Worker | 13 / 267 (4.9) | 19 / 289 (6.6) | 33 / 559 (5.9) | 0.889 |
Left Work or School Due to TB | 107 / 267 (40.1) | 140 / 289 (48.4) | 247 / 559 (44.2) | 0.026 |
Current or Former Smoker | 11 / 214 (5.1) | 28 / 268 (10.4) | 39 / 485 (8.0) | 0.051 |
Household Contact with MDR-TB | 35 / 224 (15.6) | 55 / 269 (20.4) | 90 / 496 (18.1) | 0.207 |
Pulmonary TB Only | 192 / 267 (71.9) | 221 / 289 (76.5) | 415 / 559 (74.2) | 0.168 |
Cavitary Lesions on X-ray | 118 / 227 (52.0) | 146 / 241 (60.6) | 266 / 470 (56.6) | 0.075 |
HIV Positive | 1 / 138 (0.7) | 1 / 163 (0.6) | 2 / 301 (0.7) | 1.000 |
Diabetic | 18 / 99 (18.2) | 18 / 49 (36.7) | 36 / 148 (24.3) | 0.023 |
Smear Positive | 163 / 267 (61.0) | 207 / 289 (71.6) | 372 / 559 (66.5) | 0.011 |
Culture Positive | 227 / 253 (89.7) | 254 / 277 (91.7) | 483 / 532 (90.8) | 0.527 |